Global Swine Circovirus Vaccine 麻豆原创 Research Report 2023

Publication ID:

PB510230383

Publication Date:

October 19, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Swine circovirus听(PCV) is a group of single-stranded DNA viruses (class II), that is nonenveloped with an unsegmented circular genome.
The global Swine Circovirus Vaccine market is projected to reach US$ 409 million in 2029, increasing from US$ 245 million in 2022, with the CAGR of 7.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Swine Circovirus Vaccine market research.
Porcine vaccines play a crucial role in preventing and controlling various viral, bacterial, and parasitic diseases in pigs. The market is driven by factors such as the growth of the swine industry, rising awareness about the benefits of vaccination, and the implementation of stringent animal health regulations. Additionally, advancements in vaccine technology, such as the development of more efficacious and safer vaccines, are fueling market growth. However, challenges such as high costs associated with vaccine development and production, and the presence of counterfeit vaccines in some regions, may hamper market growth. With the continuous focus on disease prevention and the need to ensure a healthy pig population, the porcine vaccines market is expected to witness sustained growth in the coming years.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Swine Circovirus Vaccine market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Chopper Biology
ChengDu Tecbond
Ringpu Biology
Qilu Animal
DHN
CAVAC
Komipharm
Jinyu Bio-Technology
Zoetis
Boehringer Ingelheim
Segment by Type
Genetic Engineering Vaccine
Killed Vaccines
Segment by Application
Piglets
Adults Pigs
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Swine Circovirus Vaccine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers鈥� Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers鈥� Outline
Chapter 7: Industry Chain, 麻豆原创 Channel and Customer Analysis
Chapter 8: 麻豆原创 Opportunities and Challenges
Chapter 9: 麻豆原创 Conclusions
Chapter 10: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Swine Circovirus Vaccine 麻豆原创 Overview
1.1 Product Overview and Scope of Swine Circovirus Vaccine
1.2 Swine Circovirus Vaccine Segment by Type
1.2.1 Global Swine Circovirus Vaccine 麻豆原创 Value Comparison by Type (2023-2029)
1.2.2 Genetic Engineering Vaccine
1.2.3 Killed Vaccines
1.3 Swine Circovirus Vaccine Segment by Application
1.3.1 Global Swine Circovirus Vaccine 麻豆原创 Value by Application: (2023-2029)
1.3.2 Piglets
1.3.3 Adults Pigs
1.4 Global Swine Circovirus Vaccine 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Swine Circovirus Vaccine Revenue 2018-2029
1.4.2 Global Swine Circovirus Vaccine Sales 2018-2029
1.4.3 Global Swine Circovirus Vaccine 麻豆原创 Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Swine Circovirus Vaccine 麻豆原创 Competition by Manufacturers
2.1 Global Swine Circovirus Vaccine Sales 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global Swine Circovirus Vaccine Revenue 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global Swine Circovirus Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global Swine Circovirus Vaccine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Swine Circovirus Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Swine Circovirus Vaccine, Product Type & Application
2.7 Swine Circovirus Vaccine 麻豆原创 Competitive Situation and Trends
2.7.1 Swine Circovirus Vaccine 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Swine Circovirus Vaccine Players 麻豆原创 Share by Revenue
2.7.3 Global Swine Circovirus Vaccine 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Swine Circovirus Vaccine Retrospective 麻豆原创 Scenario by Region
3.1 Global Swine Circovirus Vaccine 麻豆原创 Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Swine Circovirus Vaccine Global Swine Circovirus Vaccine Sales by Region: 2018-2029
3.2.1 Global Swine Circovirus Vaccine Sales by Region: 2018-2023
3.2.2 Global Swine Circovirus Vaccine Sales by Region: 2024-2029
3.3 Global Swine Circovirus Vaccine Global Swine Circovirus Vaccine Revenue by Region: 2018-2029
3.3.1 Global Swine Circovirus Vaccine Revenue by Region: 2018-2023
3.3.2 Global Swine Circovirus Vaccine Revenue by Region: 2024-2029
3.4 North America Swine Circovirus Vaccine 麻豆原创 Facts & Figures by Country
3.4.1 North America Swine Circovirus Vaccine 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Swine Circovirus Vaccine Sales by Country (2018-2029)
3.4.3 North America Swine Circovirus Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Swine Circovirus Vaccine 麻豆原创 Facts & Figures by Country
3.5.1 Europe Swine Circovirus Vaccine 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Swine Circovirus Vaccine Sales by Country (2018-2029)
3.5.3 Europe Swine Circovirus Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Swine Circovirus Vaccine 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Swine Circovirus Vaccine 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Swine Circovirus Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Swine Circovirus Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Swine Circovirus Vaccine 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Swine Circovirus Vaccine 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Swine Circovirus Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Swine Circovirus Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Swine Circovirus Vaccine 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Swine Circovirus Vaccine 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Swine Circovirus Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Swine Circovirus Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Swine Circovirus Vaccine Sales by Type (2018-2029)
4.1.1 Global Swine Circovirus Vaccine Sales by Type (2018-2023)
4.1.2 Global Swine Circovirus Vaccine Sales by Type (2024-2029)
4.1.3 Global Swine Circovirus Vaccine Sales 麻豆原创 Share by Type (2018-2029)
4.2 Global Swine Circovirus Vaccine Revenue by Type (2018-2029)
4.2.1 Global Swine Circovirus Vaccine Revenue by Type (2018-2023)
4.2.2 Global Swine Circovirus Vaccine Revenue by Type (2024-2029)
4.2.3 Global Swine Circovirus Vaccine Revenue 麻豆原创 Share by Type (2018-2029)
4.3 Global Swine Circovirus Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Swine Circovirus Vaccine Sales by Application (2018-2029)
5.1.1 Global Swine Circovirus Vaccine Sales by Application (2018-2023)
5.1.2 Global Swine Circovirus Vaccine Sales by Application (2024-2029)
5.1.3 Global Swine Circovirus Vaccine Sales 麻豆原创 Share by Application (2018-2029)
5.2 Global Swine Circovirus Vaccine Revenue by Application (2018-2029)
5.2.1 Global Swine Circovirus Vaccine Revenue by Application (2018-2023)
5.2.2 Global Swine Circovirus Vaccine Revenue by Application (2024-2029)
5.2.3 Global Swine Circovirus Vaccine Revenue 麻豆原创 Share by Application (2018-2029)
5.3 Global Swine Circovirus Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Chopper Biology
6.1.1 Chopper Biology Corporation Information
6.1.2 Chopper Biology Description and Business Overview
6.1.3 Chopper Biology Swine Circovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Chopper Biology Swine Circovirus Vaccine Product Portfolio
6.1.5 Chopper Biology Recent Developments/Updates
6.2 ChengDu Tecbond
6.2.1 ChengDu Tecbond Corporation Information
6.2.2 ChengDu Tecbond Description and Business Overview
6.2.3 ChengDu Tecbond Swine Circovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 ChengDu Tecbond Swine Circovirus Vaccine Product Portfolio
6.2.5 ChengDu Tecbond Recent Developments/Updates
6.3 Ringpu Biology
6.3.1 Ringpu Biology Corporation Information
6.3.2 Ringpu Biology Description and Business Overview
6.3.3 Ringpu Biology Swine Circovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Ringpu Biology Swine Circovirus Vaccine Product Portfolio
6.3.5 Ringpu Biology Recent Developments/Updates
6.4 Qilu Animal
6.4.1 Qilu Animal Corporation Information
6.4.2 Qilu Animal Description and Business Overview
6.4.3 Qilu Animal Swine Circovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Qilu Animal Swine Circovirus Vaccine Product Portfolio
6.4.5 Qilu Animal Recent Developments/Updates
6.5 DHN
6.5.1 DHN Corporation Information
6.5.2 DHN Description and Business Overview
6.5.3 DHN Swine Circovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 DHN Swine Circovirus Vaccine Product Portfolio
6.5.5 DHN Recent Developments/Updates
6.6 CAVAC
6.6.1 CAVAC Corporation Information
6.6.2 CAVAC Description and Business Overview
6.6.3 CAVAC Swine Circovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 CAVAC Swine Circovirus Vaccine Product Portfolio
6.6.5 CAVAC Recent Developments/Updates
6.7 Komipharm
6.6.1 Komipharm Corporation Information
6.6.2 Komipharm Description and Business Overview
6.6.3 Komipharm Swine Circovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Komipharm Swine Circovirus Vaccine Product Portfolio
6.7.5 Komipharm Recent Developments/Updates
6.8 Jinyu Bio-Technology
6.8.1 Jinyu Bio-Technology Corporation Information
6.8.2 Jinyu Bio-Technology Description and Business Overview
6.8.3 Jinyu Bio-Technology Swine Circovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Jinyu Bio-Technology Swine Circovirus Vaccine Product Portfolio
6.8.5 Jinyu Bio-Technology Recent Developments/Updates
6.9 Zoetis
6.9.1 Zoetis Corporation Information
6.9.2 Zoetis Description and Business Overview
6.9.3 Zoetis Swine Circovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Zoetis Swine Circovirus Vaccine Product Portfolio
6.9.5 Zoetis Recent Developments/Updates
6.10 Boehringer Ingelheim
6.10.1 Boehringer Ingelheim Corporation Information
6.10.2 Boehringer Ingelheim Description and Business Overview
6.10.3 Boehringer Ingelheim Swine Circovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Boehringer Ingelheim Swine Circovirus Vaccine Product Portfolio
6.10.5 Boehringer Ingelheim Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Swine Circovirus Vaccine Industry Chain Analysis
7.2 Swine Circovirus Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Swine Circovirus Vaccine Production Mode & Process
7.4 Swine Circovirus Vaccine Sales and 麻豆原创ing
7.4.1 Swine Circovirus Vaccine Sales Channels
7.4.2 Swine Circovirus Vaccine Distributors
7.5 Swine Circovirus Vaccine Customers
8 Swine Circovirus Vaccine 麻豆原创 Dynamics
8.1 Swine Circovirus Vaccine Industry Trends
8.2 Swine Circovirus Vaccine 麻豆原创 Drivers
8.3 Swine Circovirus Vaccine 麻豆原创 Challenges
8.4 Swine Circovirus Vaccine 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Chopper Biology
ChengDu Tecbond
Ringpu Biology
Qilu Animal
DHN
CAVAC
Komipharm
Jinyu Bio-Technology
Zoetis
Boehringer Ingelheim

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.